Latest disclosed trades
Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.
See the tradesUpdated Oct 17 · 2 feeds behind: Insider filings, 2 days, and 1 more · Every feed →
INM · 146 trades
Trades
146
Buys 146 · Sells 0
People
6
Stocks
1
Disclosed value
$2.1M
range midpoints · Congress & executive
Filed late
64
- ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$2.3Kdisclosed Jul 2 · filed the same day
- ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$85disclosed Jul 2 · filed 2 days after the trade
- ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$6.1Kdisclosed Jul 2 · filed 1 day after the trade
- ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$2.3Kdisclosed Jul 2 · filed the same day
- ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$617disclosed Jul 2 · filed 1 day after the trade
- ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$6.1Kdisclosed Jul 2 · filed 1 day after the trade
- ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$839disclosed Jul 2 · filed 2 days after the trade
- ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$2.3Kdisclosed Jul 2 · filed the same day
- ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$2.3Kdisclosed Jul 2 · filed the same day
- ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$228disclosed Jul 2 · filed the same day
- ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$839disclosed Jul 2 · filed 2 days after the trade
- ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$617disclosed Jul 2 · filed 1 day after the trade
- ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$85disclosed Jul 2 · filed 2 days after the trade
- ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$839disclosed Jul 2 · filed 2 days after the trade
- ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$617disclosed Jul 2 · filed 1 day after the trade
- ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$85disclosed Jul 2 · filed 2 days after the trade
- ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$228disclosed Jul 2 · filed the same day
- ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$85disclosed Jul 2 · filed 2 days after the trade
- ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$228disclosed Jul 2 · filed the same day
- ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$6.1Kdisclosed Jul 2 · filed 1 day after the trade
- ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$839disclosed Jul 2 · filed 2 days after the trade
- ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$228disclosed Jul 2 · filed the same day
- ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$617disclosed Jul 2 · filed 1 day after the trade
- ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$6.1Kdisclosed Jul 2 · filed 1 day after the trade
- ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$5.3Kdisclosed Jun 10 · filed 20 days after the trade · late